How Clinicians Conceptualize “Actionability” in Genomic Screening
Over the last decade, the concept of actionability has become a primary framework for assessing whether genetic data is useful and appropriate to return to patients. Despite the popularity of this concept, there is little consensus about what should count as “actionable” information. This is particu...
Main Authors: | Kellie Owens, Pamela Sankar, Dina M. Asfaha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/2/290 |
Similar Items
-
Ethical issues raised by new genomic technologies: the case study of newborn genome screening
by: Rachel Horton, et al.
Published: (2023-01-01) -
Ethical and Psychosocial Implications of Genomic Newborn Screening
by: Harvey L. Levy
Published: (2021-01-01) -
Newborn Screening Is on a Collision Course with Public Health Ethics
by: Robert J. Currier
Published: (2022-09-01) -
Functional genomics and compound mode-of-action screening in haploid human cells
by: Gapp, B
Published: (2017) -
Anscombe’s Account of Voluntary Action in “Intention”
by: Jean-Philippe Narboux
Published: (2020-03-01)